Evidence map›Paper›PMID 41321037›Full record

ArticleEuropean journal of haematology2026

When TIVADs Won't Let Go: Lessons Learned From a Pediatric Oncology Cohort in Southern Chile.

Albert Pasten, Lucas Alvarado, Andrea Fernandez, Julio Yévenes

Abstract read
In one paragraph

Article in European journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Albert PastenDepartment of Surgery, Faculty of Medicine, University of Concepcion, Concepcion, Chile.ORCID https://orcid.org/0000-0001-5231-9564
Lucas AlvaradoBachelor of Science in Nursing, University of Concepcion, Concepcion, Chile.
Andrea FernandezStatistical Engineer, Faculty of Medicine, University of Concepcion, Concepcion, Chile.
Julio YévenesPediatric Surgeon, Hospital Guillermo Grant Benavente, Concepcion, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTotally implantable venous access devices (TIVADs) are essential in pediatric oncology but can cause mechanical complications at removal. Identifying risk factors helps guide management and timing of elective removal. Our objective is to describe the incidence and determinants of mechanical complications that occur during the removal of TIVADs in a Chilean tertiary pediatric oncology center.

methodsWe performed a retrospective cross-sectional review of all TIVAD removal episodes at Hospital Guillermo Grant Benavente (Concepción, Chile) between June 2022 and May 2025. Demographic, oncologic, and device variables were collected; univariate comparisons examined associations with mechanical outcomes.

resultsSixty-eight removals were analyzed. Mechanical complications occurred in 29.4% of procedures: difficult removal in 20 cases (29.4%), catheter retention in 12 (17.6%), and catheter fracture in 3 (4.4%). Mean indwelling time was greater in fractured devices (6.1 ± 0.6 years) compared with non-fractured devices (4.4 ± 1.7 years; p = 0.026), and longer in difficult removals (5.1 ± 1.2 vs. 4.2 ± 1.3 years; p = 0.011). Open technique was borderline associated with difficult removal (p = 0.050).

conclusionsProlonged indwelling time and open technique are the principal factors associated with mechanical problems during TIVAD removal. These findings support early recognition of high-risk devices and consideration of timely replacement or elective removal to reduce avoidable complications.

Indexed as

Catheterization, Central VenousCatheters, IndwellingDevice RemovalNeoplasmsAdolescentChildChild, PreschoolChileCross-Sectional StudiesFemaleHumansMaleRetrospective StudiesRisk Factorscancerdevice removalpediatricsrisk factorsvascular access ports

Identifiers

PMID41321037
PMCPMC13460943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.